Literature DB >> 9606616

Analgesic abuse in the elderly. Renal sequelae and management.

M M Elseviers1, M E De Broe.   

Abstract

Nephropathy caused by the use of 'classical' analgesics [paracetamol (acetaminophen), salicylates and pyrazolone derivatives] and renal impairment associated with nonsteroidal anti-inflammatory drugs (NSAIDs) are important health problems in the elderly. Classical analgesic nephropathy is a chronic renal disease characterised by renal papillary necrosis and chronic interstitial nephritis. The nephropathy is caused by the excessive consumption of analgesic mixtures containing at least 2 antipyretic analgesics combined with caffeine and/or codeine. The use of NSAIDs is associated with a wide range of tubular, interstitial, glomerular and vascular renal lesions. Despite the well-characterised acute biological effects of NSAIDs on the kidney, there is only limited evidence that they are associated with an increased risk of chronic renal failure. Classical analgesic toxicity can be effectively prevented by limiting the availability of over-the-counter analgesic mixtures containing 2 analgesic compounds in combination with potentially addictive substances (e.g. caffeine and/or codeine). In the elderly in particular, the prolonged, regular use of NSAIDs should be discouraged. Patients starting NSAID therapy should be monitored regularly and drug interactions should be avoided.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9606616     DOI: 10.2165/00002512-199812050-00005

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  52 in total

1.  Interpretation of creatinine clearance.

Authors:  M M Elseviers; G A Verpooten; M E De Broe; G G De Backer
Journal:  Lancet       Date:  1987-02-21       Impact factor: 79.321

2.  Epidemiologic study of abuse of analgesics containing phenacetin. Renal morbidity and mortality (1968-1979).

Authors:  U C Dubach; B Rosner; E Pfister
Journal:  N Engl J Med       Date:  1983-02-17       Impact factor: 91.245

Review 3.  Concerns with chronic analgesic therapy in elderly patients.

Authors:  F M Gloth
Journal:  Am J Med       Date:  1996-07-31       Impact factor: 4.965

Review 4.  Combination analgesic-induced kidney disease: the Australian experience.

Authors:  G G Duggin
Journal:  Am J Kidney Dis       Date:  1996-07       Impact factor: 8.860

Review 5.  Renal toxicity of the nonsteroidal anti-inflammatory drugs.

Authors:  M D Murray; D C Brater
Journal:  Annu Rev Pharmacol Toxicol       Date:  1993       Impact factor: 13.820

6.  Epidemiologic study of regular analgesic use and end-stage renal disease.

Authors:  T G Murray; P D Stolley; J C Anthony; R Schinnar; E Hepler-Smith; J L Jeffreys
Journal:  Arch Intern Med       Date:  1983-09

Review 7.  Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance.

Authors:  A G Johnson; P Seideman; R O Day
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

Review 8.  NSAID-related adverse drug interactions with clinical relevance. An update.

Authors:  A G Johnson; P Seidemann; R O Day
Journal:  Int J Clin Pharmacol Ther       Date:  1994-10       Impact factor: 1.366

9.  Subclinical renal toxicity in rheumatic patients receiving longterm treatment with nonsteroidal antiinflammatory drugs.

Authors:  J Calvo-Alén; M A De Cos; V Rodríguez-Valverde; R Escallada; J Florez; M Arias
Journal:  J Rheumatol       Date:  1994-09       Impact factor: 4.666

Review 10.  Interstitial nephritis, the nephrotic syndrome, and chronic renal failure secondary to nonsteroidal anti-inflammatory drugs.

Authors:  D Kleinknecht
Journal:  Semin Nephrol       Date:  1995-05       Impact factor: 5.299

View more
  1 in total

Review 1.  Emergency orthogeriatrics: concepts and therapeutic alternatives.

Authors:  Christopher R Carpenter; Michael E Stern
Journal:  Emerg Med Clin North Am       Date:  2010-11       Impact factor: 2.264

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.